Trial record 100 of 115 for: "Viral Infectious Disease" | "Ledipasvir"
Impact of Antiviral Therapy on Gastroesophageal Varices.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02758509|
Recruitment Status : Completed
First Posted : May 2, 2016
Last Update Posted : May 21, 2018
Parc de Salut Mar
Information provided by (Responsible Party):
José Antonio Carrion, Parc de Salut Mar
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||June 15, 2017|
|Actual Study Completion Date :||October 15, 2017|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Puigvehí M, Londoño MC, Torras X, Lorente S, Vergara M, Morillas RM, Masnou H, Serrano T, Miquel M, Gallego A, Lens S, Carrión JA. Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patients. J Gastroenterol. 2019 Sep 6. doi: 10.1007/s00535-019-01619-0. [Epub ahead of print]